Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

General Medicine

Clinical Pharmacology

Effect of the million hearts cardiovascular disease risk reduction model on initiating and intensifying medications

JAMA | Jun 09, 2021 Clinical Pharmacology

Sacubitril/valsartan vs enalapril on exercise capacity in patients with heart failure with reduced ejection fraction: A randomized, double-blind, active-controlled study

American Heart Journal | Jun 09, 2021 Clinical Pharmacology

Use of statin for the primary prevention of cardiovascular outcomes in elderly patients: A propensity-matched cohort study

Atherosclerosis | Jun 09, 2021 Clinical Pharmacology

Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-AD7 Phase 3 randomized trial

Journal of the European Academy of Dermatology and Venereology | Jun 09, 2021 Clinical Pharmacology

Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: Insights from the VICTORIA (Vericiguat Global Study in Subjects with HFrEF) trial

European Journal of Heart Failure | Jun 07, 2021 Clinical Pharmacology

Growth differentiation factor-15, treatment with liraglutide, and clinical outcomes among patients with heart failure

ESC Heart Failure | Jun 07, 2021 Clinical Pharmacology

Real-life use of onabotulinumtoxina reduces healthcare resource utilization in individuals with chronic migraine: The REPOSE study

The Journal of Headache and Pain | Jun 06, 2021 Clinical Pharmacology

Effect of azithromycin on bronchial wall thickness in severe persistent asthma: A double-blind placebo-controlled randomized clinical trial

Respiratory Medicine | Jun 05, 2021 Clinical Pharmacology

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): A randomised controlled, open-label, platform trial

The Lancet | Jun 04, 2021 Clinical Pharmacology

IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): A double-blind, randomised, placebo-controlled, phase 2 trial

The Lancet | Jun 04, 2021 Clinical Pharmacology

« Prev 1 … 60 61 62 63 64 … 338 Next »

Effect of the million hearts cardiovascular disease risk reduction model on initiating and intensifying medications

Sacubitril/valsartan vs enalapril on exercise capacity in patients with heart failure with reduced ejection fraction: A randomized, double-blind, active-controlled study

Use of statin for the primary prevention of cardiovascular outcomes in elderly patients: A propensity-matched cohort study

Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-AD7 Phase 3 randomized trial

Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: Insights from the VICTORIA (Vericiguat Global Study in Subjects with HFrEF) trial

Growth differentiation factor-15, treatment with liraglutide, and clinical outcomes among patients with heart failure

Real-life use of onabotulinumtoxina reduces healthcare resource utilization in individuals with chronic migraine: The REPOSE study

Effect of azithromycin on bronchial wall thickness in severe persistent asthma: A double-blind placebo-controlled randomized clinical trial

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): A randomised controlled, open-label, platform trial

IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): A double-blind, randomised, placebo-controlled, phase 2 trial

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Pulmonary Embolism: MCQs Challenge

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

Top Foods to Combat Winter Illness

Effect of the million hearts cardiovascular disease risk reduction model on initiating and intensifying medications

Sacubitril/valsartan vs enalapril on exercise capacity in patients with heart failure with reduced ejection fraction: A randomized, double-blind, active-controlled study

Use of statin for the primary prevention of cardiovascular outcomes in elderly patients: A propensity-matched cohort study

Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-AD7 Phase 3 randomized trial

Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: Insights from the VICTORIA (Vericiguat Global Study in Subjects with HFrEF) trial

Growth differentiation factor-15, treatment with liraglutide, and clinical outcomes among patients with heart failure

Real-life use of onabotulinumtoxina reduces healthcare resource utilization in individuals with chronic migraine: The REPOSE study

Effect of azithromycin on bronchial wall thickness in severe persistent asthma: A double-blind placebo-controlled randomized clinical trial

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): A randomised controlled, open-label, platform trial

IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): A double-blind, randomised, placebo-controlled, phase 2 trial

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Pulmonary Embolism: MCQs Challenge

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

Top Foods to Combat Winter Illness

Select Specialty

Select Topic